Literature DB >> 23478525

Optimal management of gastric cancer: results from an international RAND/UCLA expert panel.

Natalie Coburn1, Rajini Seevaratnam, Lawrence Paszat, Lucy Helyer, Calvin Law, Carol Swallow, Roberta Cardosa, Alyson Mahar, Laercio Gomes Lourenco, Matthew Dixon, Tanios Bekaii-Saab, Ian Chau, Neal Church, Daniel Coit, Christopher H Crane, Craig Earle, Paul Mansfield, Norman Marcon, Thomas Miner, Sung Hoon Noh, Geoff Porter, Mitchell C Posner, Vivek Prachand, Takeshi Sano, Cornelis van de Velde, Sandra Wong, Robin McLeod.   

Abstract

OBJECTIVE: Defining processes of care, which are appropriate and necessary for management of gastric cancer (GC), is an important step toward improving outcomes.
METHODS: Using a RAND/UCLA Appropriateness Method, an international multidisciplinary expert panel created 22 statements reflecting optimal management. All statements were scored for appropriateness and necessity.
RESULTS: The following tenets were scored appropriate and necessary: (1) preoperative staging by computed tomography of abdomen/pelvis; (2) positron-emission tomographic scans not routinely indicated; (3) consideration for adjuvant therapy; (4) further clinical trials; (5) multidisciplinary decision making; (6) sufficient support at hospitals; (7) assessment of 16 or more lymph nodes (LNs); (8) in metastatic disease, surgery only for palliation of major symptoms; (9) surgeons experienced in GC management; (10) and surgeons experienced in both GC management and advanced laparoscopic surgery for laparoscopic resection. The following were scored appropriate, but of indeterminate necessity: (1) diagnostic laparoscopy before treatment; (2) a multidisciplinary approach to linitis plastica; (3) genetic assessment for diffuse GC and family history, or age less than 45 years; (4) endoscopic removal of select T1aN0 lesions; (5) D2 LN dissection in curative intent cases; (6) D1 LN dissection for early GC or patients with comorbidities; (7) frozen section analysis of margins; (8) nonemergent cases performed in a hospital with a volume of more than 15 resections per year; and (9) by a surgeon with more than 6 resection per year.
CONCLUSIONS: The expert panel has created 22 statements for the perioperative management of GC patients, to provide guidance to clinicians and improve the care received by patients.

Entities:  

Mesh:

Year:  2014        PMID: 23478525     DOI: 10.1097/SLA.0b013e318288dd2b

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  22 in total

Review 1.  Modern imaging techniques for preoperative detection of distant metastases in gastric cancer.

Authors:  Robert M Kwee; Thomas C Kwee
Journal:  World J Gastroenterol       Date:  2015-10-07       Impact factor: 5.742

Review 2.  Imaging strategies in the management of gastric cancer: current role and future potential of MRI.

Authors:  Alicia S Borggreve; Lucas Goense; Hylke J F Brenkman; Stella Mook; Gert J Meijer; Frank J Wessels; Marcel Verheij; Edwin P M Jansen; Richard van Hillegersberg; Peter S N van Rossum; Jelle P Ruurda
Journal:  Br J Radiol       Date:  2019-03-05       Impact factor: 3.039

3.  Short- and long-term outcomes of LigaSure versus conventional surgery for curative gastric cancer resection: a matched pair analysis.

Authors:  Haiyang Zhou; Wei Yi; Jian Zhang; Weijun Wang; Yi Wang; Wenchao Gao; Zhiqian Hu
Journal:  Gastric Cancer       Date:  2014-08-17       Impact factor: 7.370

4.  Geographic variation in surgical practice patterns and outcomes for resected nonmetastatic gastric cancer in Ontario.

Authors:  A L Mahar; A El-Sedfy; M Dixon; M Siddiqui; M Elmi; A Ritter; J Vasilevska-Ristovska; Y Jeong; L Helyer; C Law; B Zagorski; N G Coburn
Journal:  Curr Oncol       Date:  2018-10-31       Impact factor: 3.677

5.  The impact of advanced age on short-term outcomes following gastric cancer resection: an ACS-NSQIP analysis.

Authors:  Trevor D Hamilton; Alyson L Mahar; Barbara Haas; Kaitlyn Beyfuss; Calvin H L Law; Paul J Karanicolas; Natalie G Coburn; Julie Hallet
Journal:  Gastric Cancer       Date:  2017-12-11       Impact factor: 7.370

6.  Prognostic factors in metastatic gastric cancer: results of a population-based, retrospective cohort study in Ontario.

Authors:  Matthew Dixon; Alyson L Mahar; Lucy K Helyer; Jovanka Vasilevska-Ristovska; Calvin Law; Natalie G Coburn
Journal:  Gastric Cancer       Date:  2014-11-25       Impact factor: 7.370

Review 7.  Molecular diagnosis and therapy for occult peritoneal metastasis in gastric cancer patients.

Authors:  Shunsuke Kagawa; Kunitoshi Shigeyasu; Michihiro Ishida; Megumi Watanabe; Hiroshi Tazawa; Takeshi Nagasaka; Yasuhiro Shirakawa; Toshiyoshi Fujiwara
Journal:  World J Gastroenterol       Date:  2014-12-21       Impact factor: 5.742

Review 8.  Improving the outcomes in gastric cancer surgery.

Authors:  Juul J W Tegels; Michiel F G De Maat; Karel W E Hulsewé; Anton G M Hoofwijk; Jan H M B Stoot
Journal:  World J Gastroenterol       Date:  2014-10-14       Impact factor: 5.742

Review 9.  Indication of Hyperthermic Intraperitoneal Chemotherapy in Gastric Cancer (Gastripec, Gastrichip).

Authors:  Beate Rau; Linda Feldbrügge; Felix Gronau; Miguel Enrique Alberto Vilchez; Peter Thuss-Patience; Pierre Emmanuel Bonnot; Olivier Glehen
Journal:  Visc Med       Date:  2022-02-23

Review 10.  Management of colorectal cancer presenting with synchronous liver metastases.

Authors:  Ajith K Siriwardena; James M Mason; Saifee Mullamitha; Helen C Hancock; Santhalingam Jegatheeswaran
Journal:  Nat Rev Clin Oncol       Date:  2014-06-03       Impact factor: 66.675

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.